L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine